Atectura Breezhaler 160 mcg (Mometasone Furoate CAPSULE) 160 MCG

ATECTURA BREEZHALER 160 MCG is an inhalation capsule containing mometasone furoate, used for managing respiratory conditions. This medication is designed for easy administration via a Breezhaler device, offering a convenient treatment option for those requiring inhaled corticosteroids.

Strength

160 MCG

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ATECTURA BREEZHALER 160 MCG is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the airways, which can help improve breathing and reduce symptoms such as wheezing and shortness of breath. This medication is often prescribed to individuals who require long-term management of their respiratory conditions.

Side Effects

Common effects of ATECTURA BREEZHALER 160 MCG may include throat irritation, hoarseness, and a dry mouth. Some users might experience headaches or a fungal infection in the mouth or throat, known as oral candidiasis. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Precautions & Warnings

ATECTURA BREEZHALER 160 MCG should be used with caution in individuals with a history of respiratory infections or tuberculosis. It is important to follow the prescribed dosage and administration instructions to minimize the risk of side effects. Regular monitoring by a healthcare professional is recommended, especially for long-term use.

Avoid Interactions

ATECTURA BREEZHALER 160 MCG may interact with other medications, including certain antifungal and antiviral drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol should be avoided as it may exacerbate some side effects.

Frequently Asked Questions

ATECTURA BREEZHALER 160 MCG is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

ATECTURA BREEZHALER 160 MCG is administered via inhalation using the Breezhaler device. Follow the instructions provided by your healthcare professional for proper use.

Common side effects may include throat irritation, hoarseness, dry mouth, headaches, and oral candidiasis.

ATECTURA BREEZHALER 160 MCG may interact with certain antifungal and antiviral drugs. Consult your healthcare provider before combining it with other medications.

ATECTURA BREEZHALER 160 MCG is generally safe for long-term use when used as directed. Regular monitoring by a healthcare professional is recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.